ANDA 77511, held by Sun Pharma Canada. Terbinafine Hydrochloride.
As of Nov 22, 2026, ANDA 77511 (Terbinafine Hydrochloride), held by Sun Pharma Canada, was first approved by FDA on Jul 2, 2007, with 2 approved supplements and 0 published complete response letters.
Uses
| Date | Submission | Status | Documents |
|---|---|---|---|
| Jul 2, 2007 | Original application | Approved |
| Product | Active ingredient | Marketing |
|---|---|---|
| Terbinafine Hydrochloride1% · cream;topical | Terbinafine Hydrochloride | OTC |
| Feb 28, 2019 | Supplement 15Labeling · Standard review | Approved | None posted |
| Oct 22, 2014 | Supplement 5Manufacturing | Approved | None posted |
| Jul 2, 2007 | Original application | Approved |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. “What FDA's review says” is read by a model (Claude Haiku) from FDA's summary review PDF; a field is shown only if its numbers appear in the review, and each section links the review. Drugs@FDA and FDA complete response letters